O-ACE-Sys
Commercial- Indications
- Chronic wounds, Acute wounds
Company intelligence / Profile preview
The O‑ACE‑Sys® technology has won multiple innovation awards and international recognition. It holds several US, European, and Chinese patents. The company’s devices are designed to accelerate healing of chronic and acute wounds by addressing tissue hypoxia/hypoperfusion with personalized therapeutic delivery. Clinical results have been recognized in competitions but detailed published trial data are not available.
2 more assets in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on HealO Medical.